ePrivacy and GPDR Cookie Consent by TermsFeed Generator
Submit Your Proposal for the 2024 Cancer Research Grant. Deadline: May 1, 2024 |Apply Now

From Cell Lines to FFPE

Expert handling of a range of sample types, including FFPE, making even challenging samples accessible for SV detection.

Curated SV Report

Receive a curated report detailing the structural variants identified in your samples.

Detect Coding and Non-Coding SVs

Identify SVs in genes known to have clinical significance with high concordance to orthogonal datasets.

From Sample to Analysis Report

Arima Genomics Hi-C technology allows scientists to detect and discover SVs in a broad range of sample types. Every aspect of our pilot project service is designed with translational cancer researchers in mind, aiming to fast-track discoveries from the lab to clinical applications. Take advantage of special pricing on our end-to-end SV services to quickly go from sample to analysis report and move your translational research project forward.

  • Special Pricing:
    • 4 Sample SV Pilot: $14,900, a savings of $725+ per sample
    • 8 Sample SV Pilot: $28,500, a savings of $750+ per sample
    • For projects with larger scope, talk to us about how we can accommodate your needs
  • End-to-End Services: Price includes FFPE tissue processing, 100M 2×150 paired end sequencing, and SV analysis report.
  • Submission Deadline: PO must be submitted and samples must be received by March 1st to qualify for special pricing.
  • Additional Details: This promotion cannot be applied retroactively to past orders.

 

The Arima Services Team

Our services and support teams are comprised of PhD scientists, experienced technicians, and bioinformaticians. Our team’s deep understanding of cancer biology and genomics ensures that your research benefits from the latest insights and methodologies. Request a quote to get started today.

 

 

Get Started Today

Why Choose Arima Technology for SV Detection?

Discover and detect novel gene fusions, including those that are missed by other technologies

Explore and classify tumor subtypes by their epigenetic regulatory mechanisms in both coding and non-coding regions
Gain insights from a wide range of sample types, including archival FFPE specimens
Epigenetics_Icon_Arima Genomics

See how 3D genome architecture can elucidate disease mechanisms, revealing new cancer biomarkers and targets

Hear What Our Customers Have to Say

Matija Snuderl, MD

Director of Molecular Pathology and Diagnostics, NYU Langone Medical Center
“Using Arima Hi-C technology and the new FFPE sample preparation method and bioinformatics tools we’ve been widely successful in detecting structural variants in a variety of tumor samples. We are hopeful that additional insights gained with this approach will lead to improved understanding of disease mechanisms and, ultimately, the development of new therapeutic options for people with cancer.”